https://t.co/U31XXvZNlW Small-Cell Lung Carcinoma has high expression of the neuro-endocrine glycolipid, GD2 - reminiscent of Neuroblastoma. So why did Dinutuximab fail in SCLC while it succeeded in NB? Not enough effector cells? (FDA-NB indication i…
1,432 followers
1,891 followers
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topote… https://t.co/ln38B86KW5 #PublicaSergas #HULA
2,306 followers
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer https://t.co/yGQqSdWC96 #hvhebron #ohp
906 followers
New article: Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer https://t.co/XrpSydq6xq #lungcancer #oncology https://t.co/dsdnEEWH3O